References
  1. Neufeld E.F., Muenzer J. The mucopolysaccharidoses. The metabolic and molecular bases of inherited disease, 8th edition. 2001; 3421–3452.
  2. Chuang C.K., Lin S.P. Neurochemical changes and therapeutical approaches in mucopolysaccharidoses. Neurochemistry of metabolic diseaseslysosomal storage diseases, phenylketouria and Canavan disease. Trivandrum, Kerala, India: Transworld Research Network. 2007; 1–20.
  3. Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr.2004; 144(Suppl) : S27-34.
  4. Wenger D.A., Coppola S., Liu S.L. Insights into the diagnosis and treatment of lysosomal storage disorders. Arch Neurol. 2003;60 : 322–328.
  5. Ruckenstein M.J., Macdonald R.E., Clarke J.T.R., Forte V. The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review. J Otolaryngol. 1991; 20 : 177–183.
  6. Lin H.Y., Chuang C.K., Lee K.S., Lin S.P. Awareness of mucopolysaccharidosis in an otorhinolaryngologic clinic. Pediatr Neonatol . 2017; 58 : 198-199
  7. Simmons M.A., Bruce I.A., Penney S., Rothera M.P. Otorhinolaryngological manifestations of the mucopolysaccharidoses.Int J Pediatr Otorhinolaryngol. 2005; 69 : 589–595.
  8. Lin H.Y., Shih S.C., Chuang C.K., Lee K.S., Chen M.R., Lin H.C., et al. Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses. Mol Genet Metab. 2014;111 : 533-538
  9. Giugliani R., Harmatz P., Wraith J.E. Management guidelines for mucopolysaccharidosis VI. Pediatrics. 2007; 120 : 405–418.
  10. Wraith J.E., Scarpa M., Beck M., Bodamer O.A., Meirleir L.D, Guffon N., et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr. 2008; 167 : 267–277.
  11. Nashed A., Al-Saleh S., Gibbons J., MacLusky I., MacFarlane J., Riekstins A., et al. Sleep-related breathing in children with mucopolysaccharidosis. J Inherit Metab Dis. 2009; 32 : 544–550.
  12. Lin H.Y., Chen M.R., Lin C.C., Chen C.P., Lin D.S., Chuang C.K., et al. Polysomnographic characteristics in patients with mucopolysaccharidoses. Pediatr Pulmonol. 2010; 45 : 1205-1212.
  13. Lin H.Y., Chuang C.K., Chen M.R., Lin S.J, Chiu P.C., Niu D.M., et al. Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS). Orphanet J Rare Dis. 2018; 13 : 89.
  14. Cassano P., Gelardi M., Cassano M., Fiorella M.L., Fiorella R. Adeniod tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management. Int J Pediatr Otorhinolaryngol. 2003; 67 : 1303–1309.
  15. Brodsky L. Tonsillitis, tonsillectomy and adenoidectomy. In: Bailey, BJ, ed. Head and neck surgery. Otolaryngology, Philadelphia: Lippincott, 1993; 833–847.
  16. Mesolella M., Cimmino M., Cantone E., Marino A., Cozzolino M., Casa R.D., et al. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience. Acta Otorhinolaryngol Ital. 2013; 33(4) : 267–272.
  17. Motamed M., Thorne S., Narula A. Treatment of otitis media with effusion in children with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol. 2000; 53 : 121–124.
  18. Schwartz I.V.D., Ribeiro M.G., Mota J.G., Toralles M.B.P., Correia P., Horovitz D., et al. A clinical study of 77 patients with mucopolisaccharidosis type II. Acta Paediatr. 2007;96 : 63–70.
  19. Shinhar S.Y., Zablocki H., Madgy D.N. Airway management in mucopolysaccharide storage disorders. Arch Otolaryngol Head Neck Surg. 2004; 130 : 233-237.
  20. Bredenkamp J.K., Smith M.E., Dudley J.P., Williams J.C., Crumley R.L., Crockett D.M. Otolaryngologicmanifestations of the mucopolysaccharidoses. Ann Otol Rhinol Laryngol. 1992;101 : 472–478.
  21. Peck J.E. Hearing loss in Hunter’s syndrome – mucopolysaccharidosis II. Ear Hear. 1984; 5 : 243–246.
  22. Gökdoğan Ç., Altinyay Ş., Gökdoğan O., Tutar H., Gündüz B., Okur İ., et al. Audiologic evaluations of children with mucopolysaccharidosis.Braz J Otorhinolaryngol. 2016; 82 : 281-284.
  23. Pelley C.J., Kwo J., Hess D.R. Tracheomalacia in an adult with respiratory failure and Morquio syndrome. Respir Care. 2007;52 : 278–282.
  24. Yeung A.H., Cowan M.J., Horn B., Rosbe K.W. Airway management in children withmucopolysaccharidoses. Arch Otolaryngol Head Neck Surg . 2009; 135 : 73–79.
  25. Leighton S.E., Papsin B., Vellodi A., Dinwiddie R., Lane R. Disordered breathing during sleepin patients with mucopolysaccharidoses.Int J Pediatr Otorhinolaryngol . 2001; 58 : 127–138.
  26. Wraith J.E. The mucopolysaccharidoses: a clinical review and guide tomanagement. Arch Dis Child . 1995; 72 : 263–267.
  27. Wold S.M., Derkay C.S., Darrow D.H., Proud V. Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol. 2010;74 : 27–31.
  28. Chan Y.L., Lin S.P., Man T.T., Cheng C.R. Clinical experience in anesthetic management for children with mucopolysaccharidoses: Report of ten cases. Acta Paediatr Taiwan. 2001; 42 : 306-308
  29. Santamaria F., Andreucci M.V., Parenti G., Polverino M., Viggiano D., Montella S., et al. Upper airway obstructivedisease in mucopolysaccharidoses: polysomnography, computed tomography andnasal endoscopy findings. J Inherit Metab Dis. 2007; 30 : 743–749.
  30. Brittney M.C., Juraj S., Toby N.W., Mary E.W. Anesthesia for patients with mucopolysaccharidoses: Comprehensive review of the literature with emphasis on airway management. Bosn J Basic Med Sci. 2018; Feb; 18(1) : 1–7.